University of South Florida
Screening Pathological Protein Specific Antibodies as Biomarker Discovery Tools for Neurodegenerative Disease
Abstract
dc:descriptionWith the increase in the average life span, the incidence of neurodegenerative diseases also increases, among which Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common types of neurological disorders. AD and PD share the same pathogenic mechanism that involves a class of proteins called beta-amyloid (Aβ), which, under the induction of some factors, changes from its natural monomeric state to the oligomers containing β-sheet, which is neurotoxic and thus leads to cell damage or apoptosis. This study focused on the selection of antibodies used as biomarkers for AD and PD. The selection of antibodies was based on the two well-accepted biomarkers of AD and PD, i.e., Aβ proteins and α-synuclein (α-syn) Isothermal titration calorimetry (ITC) was used to determine the specific binding of individual antibodies to their target proteins.
Degree
thesis:*- Name thesis:degree_name
- Master of Science (M.S.)
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- University of South Florida
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Li, Yitong
- Contributors dc:contributor
-
- Chuanhai Cao, Ph.D.
- Umesh Jinwal, Ph.D.
- Wanling Zhou, Ph.D.
- Qingyu Xuan, Ph.D.
Subjects
dc:subject × 5Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.usf.edu/etd/9789